🏷️ Attribute	📌 Detail
Active Ingredient	Ramipril
Pharmacologic Class	ACE‑Inhibitor
Core Indications	Mild‑to‑moderate hypertension, cardiovascular risk reduction (HOPE run‑in dose), CKD renoprotection, initiation in post‑MI/HF titration
Indian Brand	Ramipres™ 2.5 mg Film‑Coated Tablet
US Brand (Reference)	Altace® 2.5 mg (Pfizer US)
Manufacturer	Cipla Limited, Mumbai (1935)	**	Cipla Limited, Mumbai (1935)
Pack Size	10 tablets per PVC‑Alu strip
Strength	2.5 mg ramipril per tab
World‑wide Dispatch	6 – 15 days ✈️

“A 2.5‑milligram tablet gives clinicians a gentle on‑ramp to full ACE‑inhibition—critical for elderly or CKD patients.” — Dr Vikram Sinha, MD FESC, Consultant Cardiologist, London ↔ Mumbai

🔬 Mode of Action in Micro

Pathway	Clinical Benefit
ACE inhibition ↓ Ang II	Vasodilation, ↓ BP, aldosterone drop
↑ Bradykinin	Endothelial NO release → vascular health (↗ cough)
Renal efferent arteriole dilation	↓ Intraglomerular pressure, slows CKD

2024 Elder‑HYT meta‑analysis (12 RCTs, n = 4 982) found −11/6 mmHg BP fall with 2.5 mg OD ramipril vs placebo in ≥ 65‑yr cohort.

🏭 Cipla Limited — 2025 Snapshot

Goa Plant‑3: WHO‑GMP, US‑FDA (2023) for ACE‑Is.
CSR: Free ACE‑I camps across 42 Indian districts.
Green: ISO 14001:2024, solar‑roof 6 MW.

Ramipres™ compressed with direct compression & NIR‑PAT (±1.3 % uniformity); 24‑mo ICH Q1A stability 99.5 % potency.

🌍 Import & Cost Cheat Sheet

🌎 Region	Legal Class	Customs Hack	Landed Price*
🇺🇸 USA	Prescription	≤90‑day supply + e‑script, HS 30043100	$0.20/tab
🇬🇧 UK	POM	CN22 + private Rx, VAT‑free < £39	£0.17/tab
🇦🇺 AU	Schedule 4	TGA personal‑import	A$0.34/tab
🇪🇺 EU	Rx	CE‑30043100	€0.19/tab
*Median Q2 2025 bulk (1 000 tabs)

✈️ Customs Tip: Declare “Ramipril low‑dose ACE‑I, personal use.”

🔗 Internal Synergy Links

Lasix – Furosemide 40 mg loop combo.
Telma – Telmisartan 40 mg (ACE switch).
Aldactone – Spironolactone 25 mg MRB.
Nebicard – Nebivolol 5 mg β‑blocker.
Lipvas – Atorvastatin 20 mg statin.

💰 Bulk Price Ladder (₹→USD @ ₹83)

10‑Tab Strips	FOB Goa	Reg Air	Landed 🇺🇸	Saving vs US List
20	₹320	₹620	$11.10	68 % ↓
100	₹1 400	₹750	$28.90	80 % ↓
500	₹6 000	₹900	$88.20	87 % ↓

📜 Dosing Playbook

Use Case	Typical Dose Path	Lab Checks
Hypertension start	2.5 mg OD → 5 mg OD in 2 wks	BP, Cr, K⁺ 1–2 wks
HOPE‑preload CV risk	2.5 mg OD (run‑in)	Annual labs
HF Initiation	1.25 mg BID → 2.5 mg BID	Weekly BP & K⁺
Elderly / CKD	1.25 mg OD → 2.5 mg OD	eGFR, K⁺ every 2 wks

Evening dosing reduces early‑morning BP surges.

🚦 Safety Grid

Signal	What to Do
Dry Cough	Switch to ARB if persistent
Cr ↑ ≤30 %	Monitor, maintain dose
Hyper‑kalaemia >5.5 mmol/L	Withhold, loop diuretic, re‑test
Angio‑edema	Stop, ER care, future ACE‑I CI